2. Academic Validation
  3. Protein Arginine Methyltransferase 5 Contributes to Paclitaxel-Induced Neuropathic Pain by Activating Transient Receptor Potential Vanilloid 1 Epigenetic Modification in Dorsal Root Ganglion

Protein Arginine Methyltransferase 5 Contributes to Paclitaxel-Induced Neuropathic Pain by Activating Transient Receptor Potential Vanilloid 1 Epigenetic Modification in Dorsal Root Ganglion

  • Anesth Analg. 2023 Jun 30. doi: 10.1213/ANE.0000000000006595.
Chou-Ming Yeh 1 2,  Cheng-Yuan Lai 3,  Hsien-Yu Peng 3 4,  Tzer-Bin Lin 5 6,  Dylan Chou 4,  Hsueh-Hsiao Wang 4,  Po-Sheng Yang 4 7,  Jen-Kun Cheng 4 8,  Yun-Chih Peng 4,  Ming-Chun Hsieh 4
Affiliations

Affiliations

  • 1 From the Division of Thoracic Surgery, Department of Health, Taichung Hospital, Executive Yuan, Taichung, Taiwan.
  • 2 Central Taiwan University of Science and Technology, Taichung, Taiwan.
  • 3 Institute of Biomedical Sciences.
  • 4 Department of Medicine, Mackay Medical College, New Taipei, Taiwan.
  • 5 Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan.
  • 6 Institute of New Drug Development, College of Medicine, China Medical University, Taichung, Taiwanand.
  • 7 Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
  • 8 Department of Anesthesiology, Mackay Memorial Hospital, Taipei, Taiwan.
PMID: 37390022 DOI: 10.1213/ANE.0000000000006595
Abstract

Background: Paclitaxel (PTX), which is a first-line chemotherapy drug used to treat various types of cancers, exhibits peripheral neuropathy as a common side effect that is difficult to treat. Protein arginine methyltransferase 5 (PRMT 5) is a key regulator of the chemotherapy response, as chemotherapy drugs induce PRMT5 expression. However, little is known about the PRMT5-mediated epigenetic mechanisms involved in PTX-induced neuropathic allodynia.

Methods: Sprague-Dawley rats were intraperitoneally given PTX to induce neuropathic pain. Biochemical analyses were conducted to measure the protein expression levels in the dorsal root ganglion (DRG) of the Animals. The von Frey test and hot plate test were used to evaluate nociceptive behaviors.

Results: PTX increased the PRMT5 (mean difference [MD]: 0.68, 95% confidence interval [CI], 0.88-0.48; P < .001 for vehicle)-mediated deposition of histone H3R2 dimethyl symmetric (H3R2me2s) at the transient receptor potential vanilloid 1 (Trpv1) promoter in the DRG. PRMT5-induced H3R2me2s recruited WD repeat domain 5 (WDR5) to increase trimethylation of lysine 4 on histone H3 (H3K4me3) at Trpv1 promoters, thus resulting in TRPV1 transcriptional activation (MD: 0.65, 95% CI, 0.82-0.49; P < .001 for vehicle) in DRG in PTX-induced neuropathic pain. Moreover, PTX increased the activity of NADPH Oxidase 4 (NOX4) (MD: 0.66, 95% CI, 0.81-0.51; P < .001 for vehicle), PRMT5-induced H3R2me2s, and WDR5-mediated H3K4me3 in the DRG in PTX-induced neuropathic pain. Pharmacological antagonism and the selective knockdown of PRMT5 in DRG neurons completely blocked PRMT5-mediated H3R2me2s, WDR5-mediated H3K4me3, or TRPV1 expression and neuropathic pain development after PTX injection. Remarkably, NOX4 inhibition not only attenuated allodynia behavior and reversed the above-mentioned signaling but also reversed NOX4 upregulation via PTX.

Conclusions: Thus, the NOX4/PRMT5-associated epigenetic mechanism in DRG has a dominant function in the transcriptional activation of TRPV1 in PTX-induced neuropathic pain.

Figures
Products